Answers are grounded in this paper and cite their sources.
Post-traumatic osteoarthritis (PTOA) is a common clinic entity in diarthrodial joints representing approximately 12% of all osteoarthritis (OA) in the hip, knee and ankle. Unlike idiopathic OA, PTOA may occur in younger patients, can affect any joint and progresses more quickly. Multiple factors are involved in development of PTOA such as severity of mechanical impact, degree of tissue damage, associated injuries, general condition and co-morbidities. Pathological processes after joint injury can temporally be separated into the acute post-traumatic phase with inflammation of joint tissues, and the chronic phase that slowly progresses through a long, clinically asymptomatic period to a symptomatic phase with joint pain and dysfunction as a result of joint destruction. The pathologic changes can affect articular cartilage, synovium and bone through mechanical, cellular and metabolic changes. Up till now, there are no approved therapies to address the acute PTA and prevent the onset of the chronic disease. Surgical intervention along with technologic advances in fracture fixation and ligament reconstruction will undoubtedly play a role in prevention of PTOA development. However, a significant number of patients still progress to clinical OA even with the best surgical care of joint injuries.
No takes yet. Share an insight, caveat, or question.
Mohamed Elalfy (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: